Completed
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
NCT06331624
- Conditions
- IPF, Idiopathic Pulmonary Fibrosis, Lung Diseases, +3 more
- Locations
-
- Newport Native MD, Inc. Newport Beach, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Montefiore Medical Center The Bronx, New York, United States
- Southeastern Research Center Winston-Salem, North Carolina, United States